Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2045

1.

Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4.

Yamamura S, Izumiya Y, Araki S, Nakamura T, Kimura Y, Hanatani S, Yamada T, Ishida T, Yamamoto M, Onoue Y, Arima Y, Yamamoto E, Sunagawa Y, Yoshizawa T, Nakagata N, Bober E, Braun T, Sakamoto K, Kaikita K, Morimoto T, Yamagata K, Tsujita K.

Hypertension. 2019 Nov 18:HYPERTENSIONAHA11913357. doi: 10.1161/HYPERTENSIONAHA.119.13357. [Epub ahead of print]

PMID:
31735083
2.

Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial.

Chihara A, Tanaka A, Morimoto T, Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Ueda S, Node K.

Cardiovasc Diabetol. 2019 Nov 16;18(1):158. doi: 10.1186/s12933-019-0965-3.

3.

Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression.

Nakamae I, Morimoto T, Shima H, Shionyu M, Fujiki H, Yoneda-Kato N, Yokoyama T, Kanaya S, Kakiuchi K, Shirai T, Meiyanto E, Kato JY.

Molecules. 2019 Nov 10;24(22). pii: E4067. doi: 10.3390/molecules24224067.

4.

Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.

Natsuaki M, Morimoto T, Shiomi H, Yamaji K, Watanabe H, Shizuta S, Kato T, Ando K, Nakagawa Y, Furukawa Y, Tada T, Nagao K, Kadota K, Toyofuku M, Kimura T.

Circ Cardiovasc Interv. 2019 Nov;12(11):e008307. doi: 10.1161/CIRCINTERVENTIONS.119.008307. Epub 2019 Nov 11.

PMID:
31707804
5.

Insufficient accommodation during binocular near viewing in eyes with intermittent exotropia.

Morimoto T, Kanda H, Hirota M, Nishida K, Fujikado T.

Jpn J Ophthalmol. 2019 Nov 9. doi: 10.1007/s10384-019-00695-2. [Epub ahead of print]

PMID:
31707606
6.

Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry.

Yamashita Y, Murata K, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Nawada R, Onodera T, Kimura T; COMMAND VTE Registry Investigators.

Thromb Res. 2019 Nov 1;184:50-57. doi: 10.1016/j.thromres.2019.10.029. [Epub ahead of print]

PMID:
31706068
7.

Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.

Natsuaki M, Morimoto T, Watanabe H, Nakagawa Y, Furukawa Y, Kadota K, Akasaka T, Hanaoka KI, Kozuma K, Tanabe K, Morino Y, Muramatsu T, Kimura T; CREDO‐Kyoto PCI/CABG registry cohort‐2, RESET and NEXT trial investigators.

J Am Heart Assoc. 2019 Nov 19;8(22):e013356. doi: 10.1161/JAHA.119.013356. Epub 2019 Nov 8.

8.

Prognostic Impact of Baseline Hemoglobin Levels on Long-Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions.

Nagao K, Watanabe H, Morimoto T, Inada T, Hayashi F, Nakagawa Y, Furukawa Y, Kadota K, Akasaka T, Natsuaki M, Kozuma K, Tanabe K, Morino Y, Shiomi H, Kimura T; CREDO‐Kyoto PCI/CABG Registry Cohort‐2, RESET, and NEXT Investigators.

J Am Heart Assoc. 2019 Nov 19;8(22):e013703. doi: 10.1161/JAHA.119.013703. Epub 2019 Nov 8.

9.

Nonuniform functional group distribution of carbon nanotubes studied by energy dispersive X-ray spectrometry imaging in SEM.

Nakajima H, Morimoto T, Zhou Y, Kobashi K, Ata S, Yamada T, Okazaki T.

Nanoscale. 2019 Nov 28;11(44):21487-21492. doi: 10.1039/c9nr07619k. Epub 2019 Nov 5.

PMID:
31686079
10.

Hyperspectral environmental illumination maps: characterizing directional spectral variation in natural environments.

Morimoto T, Kishigami S, Linhares JMM, Nascimento SMC, Smithson HE.

Opt Express. 2019 Oct 28;27(22):32277-32293. doi: 10.1364/OE.27.032277.

PMID:
31684444
11.

Evolution and Analysis of Hapkit: An Open-Source Haptic Device for Educational Applications.

Orta Martinez M, Nunez CM, Liao T, Morimoto TK, Okamura A.

IEEE Trans Haptics. 2019 Oct 21. doi: 10.1109/TOH.2019.2948609. [Epub ahead of print]

PMID:
31634847
12.

Impact of Endovascular Therapy in Patients With Large Ischemic Core: Subanalysis of Recovery by Endovascular Salvage for Cerebral Ultra-Acute Embolism Japan Registry 2

Kakita H, Yoshimura S, Uchida K, Sakai N, Yamagami H, Morimoto T; RESCUE-Japan Registry 2 Investigators.

Stroke. 2019 Apr;50(4):901-908. doi: 10.1161/STROKEAHA.118.024646. Epub 2019 Mar 18.

PMID:
31633899
13.

Eleven-year follow-up of a Japanese retinitis pigmentosa patient with an HK1 gene mutation.

Sato S, Morimoto T, Hotta K, Fujikado T, Nishida K.

Ophthalmic Genet. 2019 Oct 17:1-4. doi: 10.1080/13816810.2019.1678179. [Epub ahead of print]

PMID:
31621442
14.

Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence.

Lestari B, Nakamae I, Yoneda-Kato N, Morimoto T, Kanaya S, Yokoyama T, Shionyu M, Shirai T, Meiyanto E, Kato JY.

Sci Rep. 2019 Oct 16;9(1):14867. doi: 10.1038/s41598-019-51244-3.

15.

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer.

Iwasa T, Tsurutani J, Watanabe S, Kato R, Mizuno Y, Kojima Y, Takashima T, Matsunami N, Morimoto T, Yamamura J, Ohtani S, Tanabe Y, Yoshinami T, Takano T, Komoike Y, Nakagawa K.

BMC Cancer. 2019 Oct 16;19(1):962. doi: 10.1186/s12885-019-6200-5.

16.

Relationship between self-disclosure to first acquaintances and subjective well-being in people with schizophrenia spectrum disorders living in the community.

Yokoyama K, Morimoto T, Ichihara-Takeda S, Yoshino J, Matsuyama K, Ikeda N.

PLoS One. 2019 Oct 16;14(10):e0223819. doi: 10.1371/journal.pone.0223819. eCollection 2019. Erratum in: PLoS One. 2019 Nov 19;14(11):e0225680.

17.

Usefulness of Simplified Pulmonary Embolism Severity Index Score for Identification of Patients With Low-Risk Pulmonary Embolism and Active Cancer: From the COMMAND VTE Registry.

Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Chest. 2019 Oct 9. pii: S0012-3692(19)34003-6. doi: 10.1016/j.chest.2019.08.2206. [Epub ahead of print]

PMID:
31605702
18.

Nondestructive real-space imaging of energy dissipation distributions in randomly networked conductive nanomaterials.

Morimoto T, Ata S, Yamada T, Okazaki T.

Sci Rep. 2019 Oct 10;9(1):14572. doi: 10.1038/s41598-019-50802-z.

19.

D-dimer levels at diagnosis and long-term clinical outcomes in venous thromboembolism: from the COMMAND VTE Registry.

Oi M, Yamashita Y, Toyofuku M, Morimoto T, Motohashi Y, Tamura T, Kaitani K, Amano H, Takase T, Hiramori S, Kim K, Akao M, Kobayashi Y, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

J Thromb Thrombolysis. 2019 Sep 30. doi: 10.1007/s11239-019-01964-0. [Epub ahead of print]

PMID:
31571121
20.

Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients.

Soejima H, Ogawa H, Morimoto T, Okada S, Matsumoto C, Nakayama M, Masuda I, Jinnouchi H, Waki M, Saito Y; JPAD Trial Investigators.

J Cardiol. 2019 Sep 26. pii: S0914-5087(19)30283-7. doi: 10.1016/j.jjcc.2019.08.021. [Epub ahead of print]

PMID:
31564388
21.

Very Short Dual Antiplatelet Therapy after Drug-eluting Stent Implantation in Patients with High Bleeding Risk: Insight from the STOPDAPT-2 Trial.

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 investigators.

Circulation. 2019 Sep 27. doi: 10.1161/CIRCULATIONAHA.119.043613. [Epub ahead of print]

PMID:
31560216
22.

Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice.

Takeji Y, Taniguchi T, Morimoto T, Saito N, Ando K, Shirai S, Sakaguchi G, Arai Y, Fuku Y, Kawase Y, Komiya T, Ehara N, Kitai T, Koyama T, Watanabe S, Watanabe H, Shiomi H, Minamino-Muta E, Matsuda S, Yaku H, Yoshikawa Y, Yamazaki K, Kawatou M, Sakamoto K, Tamura T, Miyake M, Sakaguchi H, Murata K, Nakai M, Kanamori N, Izumi C, Mitsuoka H, Kato M, Hirano Y, Inada T, Nagao K, Mabuchi H, Takeuchi Y, Yamane K, Tamura T, Toyofuku M, Ishii M, Inoko M, Ikeda T, Ishii K, Hotta K, Jinnai T, Higashitani N, Kato Y, Inuzuka Y, Morikami Y, Minatoya K, Kimura T; CURRENT AS registry Investigators and the K-TAVI registry Investigators.

PLoS One. 2019 Sep 26;14(9):e0222979. doi: 10.1371/journal.pone.0222979. eCollection 2019.

23.

Cancer-Associated Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.

Sakamoto J, Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Tamura T, Nakagawa Y, Kimura T; COMMAND VTE Registry Investigators.

Circ J. 2019 Oct 25;83(11):2271-2281. doi: 10.1253/circj.CJ-19-0515. Epub 2019 Sep 20.

24.

Optimal Cutoff Value of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography for Predicting Hemodynamically Significant Coronary Artery Disease.

Matsumura-Nakano Y, Kawaji T, Shiomi H, Kawai-Miyake K, Kataoka M, Koizumi K, Matsuda A, Kitano K, Yoshida M, Watanabe H, Tazaki J, Kato T, Saito N, Shizuta S, Ono K, Togashi K, Morimoto T, Kimura T.

Circ Cardiovasc Imaging. 2019 Aug;12(8):e008905. doi: 10.1161/CIRCIMAGING.119.008905. Epub 2019 Aug 1.

PMID:
31525085
25.

Effect of Endovascular Therapy on Subsequent Decompressive Hemicraniectomy in Cardioembolic Ischemic Stroke with Proximal Intracranial Occlusion in the Anterior Circulation: Sub-Analysis of the RESCUE-Japan Registry 2.

Matsukawa H, Kiura Y, Sakai N, Yamagami H, Uchida K, Morimoto T, Kageyama H, Yoshimura S; RESCUE-Japan Registry 2 Investigators.

Cerebrovasc Dis. 2019;48(1-2):9-16. doi: 10.1159/000502313. Epub 2019 Sep 13.

PMID:
31522171
26.

Computer-assisted cognitive remediation therapy for patients with schizophrenia induces microstructural changes in cerebellar regions involved in cognitive functions.

Matsuoka K, Morimoto T, Matsuda Y, Yasuno F, Taoka T, Miyasaka T, Yoshikawa H, Takahashi M, Kitamura S, Kichikawa K, Kishimoto T.

Psychiatry Res Neuroimaging. 2019 Oct 30;292:41-46. doi: 10.1016/j.pscychresns.2019.09.001. Epub 2019 Sep 6.

PMID:
31521942
27.

Mechanism of high folate accumulation in a sake yeast other than Kyokai yeasts.

Shibata Y, Yamada T, Morimoto T, Fujii T, Akao T, Goshima T, Takahashi T, Tanaka N.

J Biosci Bioeng. 2019 Sep 9. pii: S1389-1723(19)30477-3. doi: 10.1016/j.jbiosc.2019.07.008. [Epub ahead of print]

PMID:
31515157
28.

The Feasibility and Efficacy of Social Cognition and Interaction Training for Outpatients With Schizophrenia in Japan: A Multicenter Randomized Clinical Trial.

Kanie A, Kikuchi A, Haga D, Tanaka Y, Ishida A, Yorozuya Y, Matsuda Y, Morimoto T, Fukuoka T, Takazawa S, Hagiya K, Ozawa S, Iwata K, Ikebuchi E, Nemoto T, Roberts DL, Nakagome K.

Front Psychiatry. 2019 Aug 23;10:589. doi: 10.3389/fpsyt.2019.00589. eCollection 2019.

29.

Downward Terrestrial Gamma-Ray Flash Observed in a Winter Thunderstorm.

Wada Y, Enoto T, Nakazawa K, Furuta Y, Yuasa T, Nakamura Y, Morimoto T, Matsumoto T, Makishima K, Tsuchiya H.

Phys Rev Lett. 2019 Aug 9;123(6):061103. doi: 10.1103/PhysRevLett.123.061103.

PMID:
31491171
30.

Secondary Gastrointestinal Amyloidosis Due to Bronchiectasis.

Morimoto T, Uchimura K, Tachiwada T, Yatera K.

Intern Med. 2019 Sep 3. doi: 10.2169/internalmedicine.3673-19. [Epub ahead of print] No abstract available.

31.

The efficacy of extended metacognitive training for psychosis: A randomized controlled trial.

Ishikawa R, Ishigaki T, Shimada T, Tanoue H, Yoshinaga N, Oribe N, Morimoto T, Matsumoto T, Hosono M.

Schizophr Res. 2019 Aug 27. pii: S0920-9964(19)30347-0. doi: 10.1016/j.schres.2019.08.006. [Epub ahead of print]

PMID:
31471248
32.

Reconstruction Geometric and Optical Parameters of Non-Planar Objects with Thin Film.

Kobayashi Y, Morimoto T, Sato I, Mukaigawa Y, Tomono T, Ikeuchi K.

IEEE Trans Pattern Anal Mach Intell. 2019 Aug 26. doi: 10.1109/TPAMI.2019.2937515. [Epub ahead of print]

PMID:
31449008
33.

Surgical Ineligibility and Long-Term Outcomes in Patients With Severe Coronary Artery Disease.

Matsumura-Nakano Y, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Yamaji K, Shizuta S, Sakata R, Hanyu M, Shimamoto M, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Circ J. 2019 Sep 25;83(10):2061-2069. doi: 10.1253/circj.CJ-19-0440. Epub 2019 Aug 22.

34.

More- Versus Less-Intensive Lipid-Lowering Therapy.

Toyota T, Morimoto T, Yamashita Y, Shiomi H, Kato T, Makiyama T, Nakagawa Y, Saito N, Shizuta S, Ono K, Kimura T.

Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005460. doi: 10.1161/CIRCOUTCOMES.118.005460. Epub 2019 Aug 15.

PMID:
31412729
35.

Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).

Watanabe H, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Tazaki J, Watanabe H, Natsuaki M, Minatoya K, Hanyu M, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG registry/cohort-2 investigators.

Catheter Cardiovasc Interv. 2019 Aug 7. doi: 10.1002/ccd.28420. [Epub ahead of print]

PMID:
31389659
36.

A Risk Prediction Model in Asymptomatic Patients with Severe Aortic Stenosis: CURRENT-AS risk score.

Minamino-Muta E, Kato T, Morimoto T, Taniguchi T, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Miyake M, Izumi C, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Inoko M, Ikeda T, Ishii K, Hotta K, Jinnai T, Kato Y, Inuzuka Y, Maeda C, Morikami Y, Saito N, Minatoya K, Kimura T.

Eur Heart J Qual Care Clin Outcomes. 2019 Aug 6. pii: qcz044. doi: 10.1093/ehjqcco/qcz044. [Epub ahead of print]

PMID:
31386103
37.

VTE and anti-coagulation therapy in cancer patients.

Miyazaki Y, Sase K, Hasegawa K, Morimoto T.

Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):189-191. doi: 10.1093/ehjcvp/pvz027. No abstract available.

PMID:
31378809
38.

Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study.

Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M.

Cancer Med. 2019 Sep;8(12):5468-5481. doi: 10.1002/cam4.2423. Epub 2019 Jul 30.

39.

Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases.

Shimizu K, Funamoto M, Sunagawa Y, Shimizu S, Katanasaka Y, Miyazaki Y, Wada H, Hasegawa K, Morimoto T.

Eur Cardiol. 2019 Jul 11;14(2):117-122. doi: 10.15420/ecr.2019.17.2. eCollection 2019 Jul. Review.

40.

Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features.

Watari J, Mitani S, Ito C, Tozawa K, Tomita T, Oshima T, Fukui H, Kadowaki S, Natsume S, Senda Y, Tajika M, Hara K, Yatabe Y, Shimizu Y, Muro K, Morimoto T, Hirota S, Das KM, Miwa H.

Sci Rep. 2019 Jul 19;9(1):10526. doi: 10.1038/s41598-019-46167-y.

41.

Reasons for Choosing Conservative Management in Symptomatic Patients With Severe Aortic Stenosis - Observations From the CURRENT AS Registry.

Ishii M, Taniguchi T, Morimoto T, Ogawa H, Masunaga N, Abe M, Yoshikawa Y, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Jinnai T, Morikami Y, Akao M, Minatoya K, Kimura T; CURRENT AS Registry Investigators.

Circ J. 2019 Aug 23;83(9):1944-1953. doi: 10.1253/circj.CJ-19-0247. Epub 2019 Jul 17.

42.

Neural changes following cognitive remediation therapy for schizophrenia.

Matsuda Y, Makinodan M, Morimoto T, Kishimoto T.

Psychiatry Clin Neurosci. 2019 Nov;73(11):676-684. doi: 10.1111/pcn.12912. Epub 2019 Aug 4. Review.

PMID:
31278805
43.

Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry.

Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators.

J Thromb Thrombolysis. 2019 Nov;48(4):587-595. doi: 10.1007/s11239-019-01913-x.

PMID:
31278648
44.

Prone "computed tomography hernia study" for the diagnosis of inguinal hernia.

Kamei N, Otsubo T, Koizumi S, Morimoto T, Nakajima Y.

Surg Today. 2019 Nov;49(11):936-941. doi: 10.1007/s00595-019-01837-2. Epub 2019 Jun 26.

PMID:
31243553
45.

The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.

Yamashita Y, Yoshikawa Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Int J Cardiol. 2019 Oct 1;292:198-204. doi: 10.1016/j.ijcard.2019.06.032. Epub 2019 Jun 13.

PMID:
31239211
46.

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators.

JAMA. 2019 Jun 25;321(24):2414-2427. doi: 10.1001/jama.2019.8145.

PMID:
31237644
47.

Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.

Kim K, Yamashita Y, Morimoto T, Kitai T, Yamane T, Ehara N, Kinoshita M, Kaji S, Amano H, Takase T, Hiramori S, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Furukawa Y, Kimura T; COMMAND VTE Registry Investigators.

Thromb Haemost. 2019 Sep;119(9):1498-1507. doi: 10.1055/s-0039-1692425. Epub 2019 Jun 23.

PMID:
31230344
48.

Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure.

Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Seko Y, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators.

JAMA Netw Open. 2019 Jun 5;2(6):e195892. doi: 10.1001/jamanetworkopen.2019.5892.

49.

Microscopic ion migration in solid electrolytes revealed by terahertz time-domain spectroscopy.

Morimoto T, Nagai M, Minowa Y, Ashida M, Yokotani Y, Okuyama Y, Kani Y.

Nat Commun. 2019 Jun 17;10(1):2662. doi: 10.1038/s41467-019-10501-9.

50.

Data on the effects of Charcot-Marie-Tooth disease type 2N-associated AARS missense mutation (Arg329-to-His) on the cell biological properties.

Imaizumi N, Takeuchi Y, Hirano H, Torii T, Seki Y, Morimoto T, Miyamoto Y, Sakagami H, Yamauchi J.

Data Brief. 2019 May 24;25:104029. doi: 10.1016/j.dib.2019.104029. eCollection 2019 Aug.

Supplemental Content

Loading ...
Support Center